Search - tctmd.com

Displaying 241 - 260 of 819

Sort: Relevancy | Date

Presentation NY Valves 2024

Natural History, Pathophysiology and Classification of Tricuspid Regurgitation

Presenter: Yan Topilsky

June 07, 2024

Presentation NY Valves 2024

Anatomical Overview of Mitral vs. Tricuspid Valve with Focus on TEER

Presenter: Mark Reisman

June 07, 2024

Presentation NY Valves 2024

When is Post-LAAO Peri-Device Leak Significant?

Presenter: Christine J. Chung

June 07, 2024

Presentation NY Valves 2024

Percutaneous Treatment of Tricuspid Regurgitation With the Novel TriFlO® Device: First in Human Italian Experience

Presenter: Gian Paolo Ussia

June 06, 2024

Presentation NY Valves 2024

CON: TMVR Has too Many Problems – Just Do M-TEER

Presenter: Saibal Kar

June 06, 2024

Presentation NY Valves 2024

Expanding Beyond Isolated RAVR – Widening the Offering in Complex Scenarios

Presenter: Vinay Badhwar

June 06, 2024

Presentation NY Valves 2024

Clinical Implications of Recurrent Tricuspid Regurgitation After Transcatheter Edge-to-Edge Repair: The TRI-SPA Registry

Presenter: Julio Cesar Echarte Morales

June 06, 2024

Presentation NY Valves 2024

Halt is Not Relevant

Presenter: Stephan Windecker

June 06, 2024

Presentation NY Valves 2024

Medical, Surgical, and Transcatheter Treatment of Chronic Aortic Regurgitation

Presenter: Santiago Garcia

June 06, 2024

Presentation NY Valves 2024

Next Generation LAAO Devices: Mechanisms, Unmet Needs, and Clinical Status

Presenter: Horst Sievert

June 06, 2024

Presentation NY Valves 2024

Unsuccessful or Complicated Leaflet Modification in TAVR

Presenter: Isida Byku

June 06, 2024

Presentation NY Valves 2024

PRO: TMVR Is a Good Option for Functional MR

Presenter: Chet Rihal

June 06, 2024

Presentation NY Valves 2024

Transaxillary Non-Robotic SAVR – Yet Another Option

Presenter: Joerg Kempfert

June 06, 2024

Presentation NY Valves 2024

Long-Term Follow Up With the DUO Coaptation Valve System for the Percutaneous Treatment of Tricuspid Regurgitation: The TANDEM I Trial

Presenter: Wojtek Wojakowski

June 06, 2024

Presentation NY Valves 2024

Halt is Relevant

Presenter: Raj Makkar

June 06, 2024

Presentation NY Valves 2024

Leaflet Modification for TAV-in-TAV

Presenter: Adam B. Greenbaum

June 06, 2024

Presentation NY Valves 2024

Innovative Approaches: Solving ASD Device Retrieval Challenges Beyond the Cath Lab Norm

Presenter: Adam Habib

June 06, 2024

Presentation NY Valves 2024

Long-Term Outcomes With Medical Therapy, Transcatheter Repair, or Surgery for Isolated Tricuspid Regurgitation: A Systematic Review and Network Meta-Analysis

Presenter: Toshiki Kuno

June 06, 2024

Presentation NY Valves 2024

TELLTALE for TAV-in-SAV or TAV-in-Native

Presenter: Toby Rogers

June 06, 2024

Presentation NY Valves 2024

EFS of the Edwards SAPIEN 3 THV System With the Edwards Caval Pre-Stent for the Treatment of Reverse Caval Flow in Patients With Severe TR

Presenter: Brian P. O'Neill

June 06, 2024

Advertisement

Natural History, Pathophysiology and Classification of Tricuspid Regurgitation

Anatomical Overview of Mitral vs. Tricuspid Valve with Focus on TEER

When is Post-LAAO Peri-Device Leak Significant?

Percutaneous Treatment of Tricuspid Regurgitation With the Novel TriFlO® Device: First in Human Italian Experience

CON: TMVR Has too Many Problems – Just Do M-TEER

Expanding Beyond Isolated RAVR – Widening the Offering in Complex Scenarios

Clinical Implications of Recurrent Tricuspid Regurgitation After Transcatheter Edge-to-Edge Repair: The TRI-SPA Registry

Halt is Not Relevant

Medical, Surgical, and Transcatheter Treatment of Chronic Aortic Regurgitation

Next Generation LAAO Devices: Mechanisms, Unmet Needs, and Clinical Status

Unsuccessful or Complicated Leaflet Modification in TAVR

PRO: TMVR Is a Good Option for Functional MR

Transaxillary Non-Robotic SAVR – Yet Another Option

Long-Term Follow Up With the DUO Coaptation Valve System for the Percutaneous Treatment of Tricuspid Regurgitation: The TANDEM I Trial

Halt is Relevant

Leaflet Modification for TAV-in-TAV

Innovative Approaches: Solving ASD Device Retrieval Challenges Beyond the Cath Lab Norm

Long-Term Outcomes With Medical Therapy, Transcatheter Repair, or Surgery for Isolated Tricuspid Regurgitation: A Systematic Review and Network Meta-Analysis

TELLTALE for TAV-in-SAV or TAV-in-Native

EFS of the Edwards SAPIEN 3 THV System With the Edwards Caval Pre-Stent for the Treatment of Reverse Caval Flow in Patients With Severe TR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content